Funding for this research was provided by:
the National Key Research and Development Program of China (2022YFA1103500)
the National Natural Science Foundation of China (82222003)
the Zhejiang Provincial Natural Science Foundation of China (LR19H080001)
the Zhejiang Innovation Team Grant (2020R01006)
Received: 11 January 2023
Accepted: 28 February 2023
First Online: 21 March 2023
: In our research, all patients were obtained retrospectively with consent in compliance with The First Affiliated Hospital of Zhejiang University and The Affiliated Hangzhou First People’s Hospital and comprehensively determined by routine cytomorphological diagnostics, immunophenotyping, and molecular genetics.
: Not applicable.
: The authors declare no competing interests.